Bristol Myers Squibb, FRN 16nov2020, USD (FIGI RegS BBG00P341B42, WKN A2R18D)

Download

Copy issue information to clipboard

Copy to clipboard

Data copied to the clipboard

PDF download

Choose all Reset all

Download Cancel

International bonds, Variable rate, Senior Unsecured

Issue | Borrower

Borrower

M

*** | ***

***
S&P

*** | ***

***
F

*** | ***

***

Status

Matured

Amount

750,000,000 USD

Placement

***

Redemption (put/call option)

*** (-)

ACI

Country of risk

USA

Current coupon

Price

Yield / Duration

Placement amount

750,000,000 USD
Minimum Settlement Amount

2,000 USD
CFI RegS

DBVNGR
FIGI RegS

BBG00P341B42
Ticker

BMY F 11/16/20 REGS

Try in 7-days Trial access

Free for company representative

Get full online access to the database
Use our powerful bond screener
Track bond prices from 400+ sources
Smart Portfolio Monitoring
Evaluate advanced analytical tools

Why Cbonds?

24 Years of Market Leadership
Trusted by clients across 90 countries for decades of reliable service
Used by Financial Professionals & Fintech central banks, asset managers, fintech innovators
Convenient platform for private investors for informed investment decisions

New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

00:23 Coverage
00:40 Bond screener
00:54 Parameters
01:10 Watchlist, Mobile app
01:15 Excel Add-in

Unlock data Watch full tour

Trading chart

Stock exchange selection

More about Cbonds Estimation

No more than two exchanges can be selected for comparison at the same time

Bond is not traded; the issue is redeemed

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found:

Show all fields

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

* Data is not available within the selected subscription

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Issue information

Profile

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, ...

Show more Hide

Research report by Cbonds-PRAAMS

Save

Authorization required

Report download is available only paid Premium subscription access

Borrower

Go to the issuer page
Bristol Myers Squibb
Full borrower / issuer name

Bristol Myers Squibb
Sector

Corporate
Industry

Pharmaceutical Preparation and Biotechnology
Stocks

Bristol Myers Squibb, ordinary share
Bristol Myers Squibb, Brazilian depositary receipt (GDR)
Bristol Myers Squibb, depositary receipt

Volume

Placement amount

750,000,000 USD

Face value

Minimum Settlement Amount

2,000 USD
Outstanding face value

*** USD
Increment

*** USD
Face value

1,000 USD

Get access to the largest bond database

Try in 7-days Demo access

Free for company representative

Evaluate advanced analytical tools
Get full online access to the database
Try our powerful bond screener
Track bond prices from 400+ sources

Get access to the largest bond database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Cash flow parameters

Reference rate

3M LIBOR USD

Coupon Rate

***

Day count convention

***

Interest Accrual Date

***
Coupon frequency

*** time(s) per year
Payment currency

***
Maturity date

***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Export to Excel

Early redemption terms

***

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Placement

Placement method

Open subscription
Placement type

Public
Placement

***
Initial issue price (yield)
Geographic breakdown

***
Investor breakdown

***
Use of proceeds

General Corporate Purposes
Acquisition Financing
Use of proceeds description

Bristol-Myers Squibb expects to use the net proceeds from the Offering to fund a portion of the aggregate cash portion of the merger consideration to be paid to Celgene shareholders in connection with the Merger and to pay related fees and expenses, with any remaining proceeds being used for general corporate purposes.

Participants

Bookrunner

***, ***, ***, ***, ***, ***, ***
Depository

***, ***

Conversion and exchange

Conversion terms

***

Latest issues

Show all

Similar issues

News

18/06/2026	Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
19/03/2026	Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026
07/02/2026	Morgan Stanley Maintains "Underweight" Rating for Bristol-Myers Squibb (NYSE: BMY)
05/02/2026	Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025
10/01/2026	Bristol Myers Squibb Company (NYSE:BMY) Stock Analysis

All organization news

IFRS/US GAAP reports

2026
	I q eng
	II q eng


2025
	I q eng


	IV q eng
2024
	I q eng
	II q eng
	III q eng
	IV q eng
2023
	I q eng
	II q eng
	III q eng
	IV q eng
2022
	I q eng
	II q eng
	III q eng
	IV q eng
2021
	I q eng
	II q eng
	III q eng
	IV q eng
2020
	I q eng
	II q eng
	III q eng
	IV q eng
2019
	I q eng
	II q eng
	III q eng
	IV q eng
2018
	I q eng
	II q eng
	III q eng
	IV q eng
2017
	I q eng
	II q eng
	III q eng
	IV q eng
2016
	I q eng
	II q eng
	III q eng
	IV q eng
2015
	I q eng
	II q eng
	III q eng
	IV q eng
2014



	IV q eng

Show all Hide

Authorization required

You need to request access

Identifiers

ISIN RegS

***
Cbonds ID

535543
ISIN 144A

***
CUSIP RegS

***
CUSIP 144A

***
CFI RegS

DBVNGR
CFI 144A

DBVNGR
FIGI RegS

BBG00P341B42
FIGI 144A

BBG00P3419Z3
WKN RegS

A2R18D
Ticker

BMY F 11/16/20 REGS
Type of security by CBR

***

Show more Hide

Ratings

Bond classification

Senior Unsecured
Registered
Coupon bonds
Variable rate
Non-complex financial instruments (MiFID)
Amortization
Callable
CDO
Convertible
Dual currency bonds
For qualified investors (CIS region)
Foreign bonds
Green bonds
Guaranteed
Inflation-linked principal
Supranational bond issues
Inflation-linked coupon
Mortgage bonds
Perpetual
Payment-in-kind
Non-Marketable Securities
Redemption Linked
Restructuring
Retail bonds
Covered
Securitization
Structured product
Commercial Bonds
Subordinated
Sukuk
Trace-eligible

Show more Hide

Restructuring

***